Trial Profile
An Observational study comparing the impact of renal function associated with warfarin versus rivaroxaban in patients with non-valvular atrial fibrillation (NVAF)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 08 Oct 2016 New trial record